Skip to main content

The NPIN Community Portal will shut down on Nov. 1. Click here to learn more.

International Agencies

Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)

This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to target via traditional drug discovery methodologies.
 

Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)

This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to target via traditional drug discovery methodologies.

Closing inequities in HIV Prevention, Care and Treatment among key populations in Burkina Faso Activity (Equity KP Burkina Faso)

The closing inequities in HIV prevention, care and treatment among key populations activity seeks to support the Governments of Togo and Burkina Faso and civil society organizations, to accelerate progress toward sustainably achieving HIV epidemic control among key populations (KP) by 2030. Equity KP Burkina Faso is a five-year cooperative agreement that will be issued to a local entity to accelerate progress toward achieving sustainable HIV epidemic control among Key populations by 2030. The Equity KP Burkina Faso activity will contribute to the following objectives: 

Closing inequities in HIV Prevention, Care and Treatment among key populations in Togo Activity (Equity KP Togo)

The closing inequities in HIV prevention, care and treatment among key populations activity seeks to support the Governments of Togo and Burkina Faso and civil society organizations, to accelerate progress toward sustainably achieving HIV epidemic control among key populations (KP) by 2030. Equity KP Togo is a five-year cooperative agreement that will be issued to a local entity to accelerate progress toward achieving sustainable HIV epidemic control among Key populations by 2030. The Equity KP Togo activity will contribute to the following objectives:

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes resear

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes research in domestic and

TB-HIV Community-Led Monitoring

The activity seeks to achieve improved TB and HIV/AIDS client outcomes through supporting community-led monitoring activities that will lead to improvements in health service quality. This activity will bolster community leadership, support robust community health sector engagement and increase community participation in health system decision-making.